By Jonas Mat, Mycology Journalist
The last seven days have proven that the Kingdom of Fungi remains the frontier of scientific and industrial revolution. From the depths of the Mediterranean to the grasslands of South Africa, here is your weekly wrap-up of the most significant mycological developments.
1. Rewriting the History of the “Magic” Mushroom
A major breakthrough in fungal evolution was announced this week. Researchers from South Africa and the United States have officially identified Psilocybe ochraceocentrata, a new species found in cattle manure in South Africa and Zimbabwe. For decades, the most famous psychedelic mushroom, Psilocybe cubensis, was thought to have migrated with human-managed cattle during the 1500s.
However, genetic analysis of P. ochraceocentrata shows a divergence nearly 1.5 million years ago. This discovery suggests that “magic” mushrooms have a much deeper, wilder history in Africa than previously imagined. Interestingly, this “new” species has likely been cultivated for years under names like “Natal Super Strength” without anyone realizing it was a distinct species until now.
2. Agarikon and Turkey Tail: The Ultimate Vaccine Partners
In a stunning clinical success, a study published in BMC Immunology on March 3rd (with updates discussed this week by Paul Stamets) has found that fungal supplements can transform the vaccination experience. The trial utilized “FoTv”—a blend of Fomitopsis officinalis (Agarikon) and Trametes versicolor (Turkey Tail) mycelium.
Participants taking the supplement reported significantly fewer side effects like headaches and fatigue after receiving COVID-19 vaccines. More remarkably, their antibody levels didn’t just peak and fade; they remained sustained or even increased at the six-month mark. This suggests that mycelium serves as a powerful “immune regulator,” helping the body process vaccines more efficiently.
3. Fungi to the Rescue: The Ocean’s New Protector
The battle against toxic “red tides” may have found a fungal ally. Scientists have identified Algophthora mediterranea, a microscopic marine fungus that specifically infects and kills toxic algae (Ostreopsis cf. ovata). These algae blooms can devastate coastal ecosystems and human health. By discovering a natural parasite that can “hunt” these blooms, researchers are opening the door to bio-based environmental management that avoids harsh chemicals.
4. The $3.3 Billion Mycelium Boom
On the industrial front, the Mycelium Market is projected to hit $3.32 billion this year. We are seeing a shift from “experimental” to “essential.” In Germany, the startup MycoLutions has scaled its production of mycelium-based acoustic panels, while global giant Diageo has begun using mycelium-based outer boxes for its luxury spirits. These materials are not just biodegradable; they are proving to be superior in shock absorption and sound dampening compared to their plastic counterparts.
Sources:
- Saxe et al., “Polypore mushroom mycelia as an adjunct to COVID-19 vaccination,” BMC Immunology, March 2026.
- ScienceDaily, “Scientists Discover Tiny Ocean Fungus That Kills Toxic Algae,” March 6, 2026.
- Bioengineer.org, “Newly Discovered African Species Sheds Light on Evolutionary Origins,” March 11, 2026.
- Fortune Business Insights, “Global Mycelium Market Outlook,” March 2026.